Zacks Investment Research upgraded shares of Koninklijke DSM (OTCMKTS:RDSMY) from a sell rating to a hold rating in a research note released on Tuesday morning, Zacks.com reports.
According to Zacks, “DSM N V ADR is involved in the Chemicals Industry. Their main focus is on base materials, performance materials, materials processing, base chemicals and fine chemicals and coating resins. They are also involved in the exploration and development of oil and natural gas deposits in the North Sea, as well as the licensing of chemical technology and know-how; in addition the company produces ingredients for bakery products. DSM is a world market leader in a number of products, including caprolactam, melamine and EPDM synthetic rubber. “
Other analysts have also issued reports about the stock. JPMorgan Chase & Co. upgraded shares of Koninklijke DSM from a neutral rating to an overweight rating in a research report on Friday, July 5th. ABN Amro lowered shares of Koninklijke DSM from a buy rating to a hold rating in a research report on Monday, August 5th. Finally, ValuEngine lowered shares of Koninklijke DSM from a sell rating to a strong sell rating in a research report on Thursday, October 10th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of Hold and an average target price of $30.00.
OTCMKTS RDSMY opened at $30.15 on Tuesday. The company has a 50-day simple moving average of $30.22 and a two-hundred day simple moving average of $29.84. Koninklijke DSM has a 12-month low of $19.45 and a 12-month high of $32.25. The firm has a market cap of $21.20 billion, a price-to-earnings ratio of 17.43, a PEG ratio of 3.67 and a beta of 1.39.
About Koninklijke DSM
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and materials businesses in the Netherlands, North America, the United Kingdom, France, Germany, Switzerland, the Asia-Pacific, and internationally.. The company operates through Nutrition, Materials, and Innovation Center segments.
Read More: Net Income
Get a free copy of the Zacks research report on Koninklijke DSM (RDSMY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.